Induced pluripotent stem cells for cartilage repair: current status and future perspectives
Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/21212
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution-ShareAlike 4.0 International Licence (CC-BY-SA 4.0)
Coleccións
- GI-TCMR - Artigos [130]
- INIBIC-TCMR - Artigos [102]
- INIBIC- REUMA - Artigos [184]
Metadatos
Mostrar o rexistro completo do ítemTítulo
Induced pluripotent stem cells for cartilage repair: current status and future perspectivesAutor(es)
Data
2018-09-11Cita bibliográfica
Castro-Viñuelas R, Sanjurjo-Rodríguez C, Piñeiro-Ramil M, Hermida-Gómez T, Fuentes-Boquete IM, de Toro-Santos FJ, Blanco-García FJ, Díaz-Prado SM. Induced pluripotent stem cells for cartilage repair: current status and future perspectives. Eur Cell Mater. 2018 Sep 11;36:96-109.
Resumo
[Abstract] The establishment of cartilage regenerative medicine is an important clinical issue, but the search for cell sources able to restore cartilage integrity proves to be challenging. Human mesenchymal stromal cells (MSCs) are prone to form epiphyseal or hypertrophic cartilage and have an age-related limited proliferation. On the other hand, it is difficult to obtain functional chondrocytes from human embryonic stem cells (ESCs). Moreover, the ethical issues associated with human ESCs are an additional disadvantage of using such cells. Since their discovery in 2006, induced pluripotent stems cells (iPSCs) have opened many gateways to regenerative medicine research, especially in cartilage tissue engineering therapies. iPSCs have the capacity to overcome limitations associated with current cell sources since large numbers of autologous cells can be derived from small starting populations. Moreover, problems associated with epiphyseal or hypertrophic-cartilage formation can be overcome using iPSCs. iPSCs emerge as a promising cell source for treating cartilage defects and have the potential to be used in the clinical field. For this purpose, robust protocols to induce chondrogenesis, both in vitro an in vivo, are required. This review summarises the recent progress in iPSC technology and its applications for cartilage repair.
Palabras chave
Induced pluripotent stem cells (iPS)
Pluripotency
Cartilage
Osteoarthritis
Cell therapy
Tissue engineering
Regenerative medicine
Chodrogenesis
Pluripotency
Cartilage
Osteoarthritis
Cell therapy
Tissue engineering
Regenerative medicine
Chodrogenesis
Versión do editor
Dereitos
Creative Commons Attribution-ShareAlike 4.0 International Licence (CC-BY-SA 4.0)
ISSN
1473-2262